Skip to main content

Recordati

Recordati S.p.A. is an international pharmaceutical group based in Italy focused on the research, development, manufacturing, and marketing of specialty medicines and rare disease treatments. The company operates through Specialty & Primary Care and Rare Diseases segments, producing cardiovascular, urological, metabolic, and orphan drug formulations. Principal revenues stem from commercial sales of proprietary prescription pharmaceuticals, specialty healthcare treatments, and active pharmaceutical ingredients. Recordati serves primary care physicians, medical specialists, hospitals, pharmacies, and patients across Europe, the Americas, and international markets. The group holds a distinct global market position as a recognized specialist in orphan drugs for rare metabolic and endocrine disorders. Recordati S.p.A. is headquartered in Milan, Italy, and its ordinary shares are listed on the Euronext Milan exchange.

40 of the funds FundTelligence covers report a position in Recordati.

Legal name
Recordati S.p.A.
Sector
Health Care
Country
Italy
Funds holding it
40

Funds holding Recordati

Showing the 8 largest of 40 funds holding it.

Loading...